Catalyst Pharmaceuticals Inc. stock outperforms market on strong
Shares of Catalyst Pharmaceuticals Inc.
CPRX,
advanced 2.17% to $5.19 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average
DJIA,
rising 0.21% to 34,869.37 and the NASDAQ Composite Index
COMP,
falling 0.52% to 14,969.97. This was the stock’s fifth consecutive day of gains. Catalyst Pharmaceuticals Inc. closed $1.05 below its 52-week high ($6.24), which the company achieved on August 13th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson
JNJ,
fell 0.72% to $163.17, Pfizer Inc.
PFE,
fell 0.84% to $43.57, and Abbott Laboratories
ABT,
fell 3.05% to $120.58. Trading volume (629,783) remained 102,051 below its 50-day average volume of 731,834.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Read More: Catalyst Pharmaceuticals Inc. stock outperforms market on strong